Status:
COMPLETED
Smoking Cessation Using Motivational Therapy and Varenicline
Lead Sponsor:
Philip Diaz
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Smoking
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
People that are infected with HIV appear to be especially susceptible to the adverse effects of cigarette smoking. The purpose of this study is to determine if quitting smoking by using a specialized ...
Detailed Description
HIV-infected smokers are at increased risk for life-threatening diseases, such as pneumonia. To date, very little is known about the tobacco consumption characteristics of this at-risk population of s...
Eligibility Criteria
Inclusion
- 18 years of age and older;
- diagnosis of HIV;
- self-reported smoking on a daily basis;
- provide informed written consent
Exclusion
- persons with active psychosis or impaired mental status as judged by the clinic staff and confirmed with a Mini-Mental Status Exam)
- unable to understand spoken English
- age less than 18 years.
- pregnant women
Key Trial Info
Start Date :
October 3 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 20 2013
Estimated Enrollment :
294 Patients enrolled
Trial Details
Trial ID
NCT00701896
Start Date
October 3 2008
End Date
June 20 2013
Last Update
January 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ohio State University
Columbus, Ohio, United States, 43210